WCN26-4279 ASSOCIATION BETWEEN IMMUNOLOGICAL STIMULI AND RELAPSE OF NEPHROTIC SYNDROME IN CHILDREN: A MULTICENTER PROSPECTIVE COHORT STUDY

Shingo Ishimori(Kobe University), Kandai Nozu(Kobe University), Taishi Nada(National Center For Child Health and Development), Shinya Ishiko(Takatsuki General Hospital), Naohiro Kamiyoshi(Himeji Red Cross Hospital), Toshinori Minato(Toyooka Hospital), Hiroshi Kaito(Kobe University), Yoshitsugu Kaku(Fukuoka Children's Hospital and Medical Center for Infectious Diseases), Kenji Ishikura(Kitasato University), Tomoko Horinouchi(Kobe University), Keita Nakanishi(Kobe Kaisei Hospital), Koichi Kamei(National Center For Child Health and Development), Yuko Shima(Wakayama Medical University), Rika Fujimaru(Osaka City General Hospital)
Kidney International Reports
March 25, 2026
10.1016/j.ekir.2026.105605
Cited by 0

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135